Results 161 to 170 of about 4,419 (217)

The MDM2-p53 axis regulates norrin/frizzled4 signaling and blood-CNS barrier function. [PDF]

Sci Signal
Levey J, Abedin M, Zhang C, Odame E, Zhang L, Jo HN, Douglas K, Roehrich H, Chen Z, Junge HJ.   +9 more
europepmc   +1 more source

Pediatric chronic myeloid leukemia: A decade of clinical experience at the NBK specialized hospital for children. [PDF]

Leuk Res Rep
Bourusly M, Obaid MA, Farag N, Bourhama M, Alsharidah S, Almatar E.   +5 more
europepmc   +1 more source

Therapeutic Outcomes of Anti-VEGF Agents Versus Corticosteroids in Diabetic Macular Edema: A Comparative Review. [PDF]

Int J Mol Sci
Sanaka S, Yu M.
europepmc   +1 more source

Central Nervous System Involvement in Acute Myeloid Leukemia: From Pathophysiology to Neuroradiologic Features and the Emerging Role of Artificial Intelligence. [PDF]

J Clin Med
Christodoulou RC, Pitsillos R, Petrou V, Sarquis MD, Papageorgiou PS, Solomou EE.   +5 more
europepmc   +1 more source

Protective effects of zingerone on the retina in diabetic rats. [PDF]

Int J Ophthalmol
Utlu B, Kozan BD, Yildirim S.
europepmc   +1 more source

Hyperleukocytosis in Pediatric Patients with Acute Lymphoblastic Leukemia: Demographic and Clinical Characteristics. [PDF]

J Clin Med
Mitura-Lesiuk MM, Dubaj M, Dembowska A, Bigosiński K, Raniewicz M.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hyperleukocytosis and leukostasis in acute and chronic leukemias

Leukemia and Lymphoma, 2022
Leukostasis is a life-threatening complication of high concentrations of circulating leukemic cells, most often myeloblasts. Effective care of patients with leukostasis involves early recognition and treatment, and aggressive management of concurrent complications of the underlying leukemia.
Walid Macaron, Nicholas J Short
exaly   +3 more sources